Our Blogs, With Science We Believe In
Stay informed with news, articles, and key milestones
from PAEAN's research and development journey.
News Jan 06, 2026
Pian Biotechnology’s ‘PN-101’ Receives Domestic Clinical Phase 2 Approval
Pian Biotechnology, a leading biotech innovator, announced that its drug candidate PN-101 has received approval to enter Phase 2 domestic clinical trials. PN-101 is a next-generation therapeutic designed to target degenerative diseases by restoring mitochondrial function and improving cellular energy metabolism.
Read More
News Jan 06, 2026
Ipsel and PianBio Sign Agreement to Develop Mitochondrial Regenera
Ipsel, a leading biotechnology company, has signed a strategic agreement with PianBio, an innovative cellular therapy startup, to develop the Mitochondrial Regenera platform. The collaboration aims to create regenerative solutions targeting degenerative diseases and conditions related to cellular energy dysfunction.
Read More Headquarter : #108SB, DaeduckBiz Center
17 Techno 4-ro, Yuseong-gu, Daejeon 34013, Korea
Mail : info@paeanbio.com
Phone : 042-334-7378 | Fax : 042-334-7096
Subscribe Our News
Copyrights © 2025 All Rights Reserved by PAEAN BIOTECHNOLOGY